BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Pf04457845

a fatty acid amide hydrolase inhibitor; structure in first source Heading Mapped to: Pyridazines Urea / analogs and derivatives

8+ PubMed studies analyzed · 2 RCTs · Evidence Score: 38.3

Research Domains

Pf04457845 has been studied across 6 research domains including 💊 Pain, 🔬 Inflammation, 😴 Sleep, ⏳ Longevity & Aging, 🫘 Kidney. The primary research focus is 💊 Pain with 25% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pf04457845, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Canagliflozin
5 shared targets
cinacalcet
8 shared targets
casin
5 shared targets
darapladib
7 shared targets
Fluvastatin
4 shared targets
cyclohexyl
4 shared targets
Meclizine
7 shared targets
Puromycin
5 shared targets
Pramipexole
6 shared targets
deguelin
5 shared targets
Loading evidence profile...

This evidence profile for Pf04457845 is generated deterministically from 8 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.